[1] |
XU Jialan, YAN Hong, WEN Jun, ZHOU Zitong, WANG Siyu.
Prevalence of Potentially Inappropriate Medication in Older Adults with Cancer: a Meta-analysis
[J]. Chinese General Practice, 2025, 28(30): 3815-3822.
|
[2] |
LI Ling, LI Yaping, QIAN Shixing, NIE Jing, LU Chunhua, LI Xia.
Research on Influencing Factors and Risk Prediction of Cognitive Function in Community-dwelling Middle-aged and Elderly People
[J]. Chinese General Practice, 2025, 28(30): 3773-3778.
|
[3] |
ZHANG Yunuo, LI Ruibin, WANG Wei.
Correlation Analysis of Serum Nesfatin-1 and Ghrelin Levels with Glycolipid Metabolism and Type 2 Diabetes Mellitus
[J]. Chinese General Practice, 2025, 28(26): 3264-3270.
|
[4] |
ZHANG Ruimin, DONG Zheyi, LI Shuang, WANG Qian, CHEN Xiangmei.
Traditional Chinese Medicine Factors Associated with Diabetic Nephropathy Diagnosed by Renal Biopsy
[J]. Chinese General Practice, 2025, 28(26): 3307-3313.
|
[5] |
TANG Shangfeng, HUANG Yangzhen, ZHENG Yanxi, PAN Yangyang, XIONG Zhongbao, QING Hua, SONG Jia, WEI Yilin, DONG Heng, WANG Chunying, CHEN Manwei, ZHANG Kangkang.
Specification for the Integration of Healthcare and Prevention Services in Diabetes at the Primary Level
[J]. Chinese General Practice, 2025, 28(25): 3096-3103.
|
[6] |
YU Wenhua, LI Jianguo, DUAN Wenyan, GAO Xuyan, LI Xiaxia, ZHANG Zilong, ZHANG Li, MA Lina.
Reliability and Validity of the Function Impairment Screening Tool among Community-dwelling Older Adults
[J]. Chinese General Practice, 2025, 28(24): 3000-3004.
|
[7] |
YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan.
Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes
[J]. Chinese General Practice, 2025, 28(24): 3053-3058.
|
[8] |
WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening.
Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention
[J]. Chinese General Practice, 2025, 28(24): 2985-2992.
|
[9] |
LI Jiaxin, LIU Zhonghui, XIE Shuo, FU Zhifang, SUN Dan, JIAO Hongmei.
Trajectory in Biomarkers of Metabolic and Inflammatory States as Early Predictors of Chronic Critical Illness in Aging Patients
[J]. Chinese General Practice, 2025, 28(24): 2993-2999.
|
[10] |
LIU Yueying, WANG Xueli, LIU Yuqiu, WEI Limin.
Correlation of Fasting C-peptide to Diabetes Duration Ration and Type 2 Diabetes Mellitus Combined with Metabolism-related Fatty Liver Disease
[J]. Chinese General Practice, 2025, 28(23): 2852-2860.
|
[11] |
WANG Peng, QIU Lixia, XU Shanshan, ZHANG Yang, ZHANG Jing, DU Xiaofei.
Advances in the Co-management of Metabolism Dysfunction-associated Fatty Liver Disease and Type 2 Diabetes Mellitus
[J]. Chinese General Practice, 2025, 28(23): 2846-2851.
|
[12] |
BAI Xue, CHEN Qianqian, LI Jie.
Innovative Practices in Chronic Disease Management: a New Model for Generalist-Specialist Combination Management of Diabetes and Metabolic Dysfunction-associated Fatty Liver Disease
[J]. Chinese General Practice, 2025, 28(23): 2841-2845.
|
[13] |
ZHAO Xiaoqing, GUO Tongtong, ZHANG Xinyi, LI Linhong, ZHANG Ya, JI Lihong, DONG Zhiwei, GAO Qianqian, CAI Weiqing, ZHENG Wengui, JING Qi.
Construction and Validation of a Risk Prediction Model for Cognitive Impairment in Community-dwelling Older Adults
[J]. Chinese General Practice, 2025, 28(22): 2776-2783.
|
[14] |
SHI Xiaotian, WANG Shan, YANG Huayu, YANG Yifan, LI Xu, MA Qing.
Association between Body Mass Index and Mortality among Older Chinese: a Cohort Study
[J]. Chinese General Practice, 2025, 28(22): 2791-2797.
|
[15] |
LIU Meixia, YIN Jinnian, WU Mei, YANG Xing, ZHOU Quanxiang, YANG Jingyuan.
Impact of Body Mass Index on the Association of Triglyceride Glucose Index with Cognitive Function: a Cross-sectional Study in Rural Older Adults in Guizhou Province
[J]. Chinese General Practice, 2025, 28(22): 2806-2812.
|